Boston Scientific Corporation · Class II · Cleared Oct 28, 2025
| K-number | K252547 |
| Device name | TheraSphere 360 Y-90 Management Platform |
| Applicant | Boston Scientific Corporation |
| Product code | LLZ |
| Device class | Class II |
| Decision date | Oct 28, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 892.2050 |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov